Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1737927/000156459020052540/cgc-10q_20200930.htm
February 2023
February 2023
January 2023
December 2022
November 2022
November 2022
November 2022
October 2022
September 2022
September 2022
April 2020
March 2020
March 2020
March 2020
March 2020
February 2020
February 2020
January 2020
January 2020
January 2020
Exhibit 99.1
CANOPY GROWTH REPORTS SECOND QUARTER FISCAL 2021 FINANCIAL RESULTS
Achieved record quarterly net revenue of $135 million
Net Loss of $97 million; Adjusted EBITDA loss of $86 million, a 43% improvement versus Q2 FY20
Implementing initiatives to capture $150-$200 million of savings across our cost structure
Increased market share by 200 basis points in Canadian recreational market based on our proprietary market share tracker
Building momentum in the U.S. and establishing foundation for long-term leadership position
November 9, 2020
SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) today announced its financial results for the second quarter fiscal 2021 ended September 30, 2020. All financial information in this press release is reported in millions of Canadian dollars, unless otherwise indicated.
“Our renewed strategy of winning consumer mindshare, along with increased agility and execution, has resulted in record net revenue for the second quarter and momentum across key areas of business,” said David Klein, CEO. “Canopy Growth is positioned for continued growth as we establish a strong leadership position that is showcased through our vast portfolio of differentiated brands and products – including our industry leading cannabis-infused beverages.”
“We saw another quarter of improvement in our operating expense ratio while our marketing and R&D investments are being re-directed to drive sales,” added Mike Lee, CFO. “Importantly, our end-to-end review has identified cost savings opportunities in the range of $150-$200 million across cost of goods sold, general and administrative expenses, and inventory, and efforts are underway to quickly capture value. Leveraging ongoing improvements across our business, we are accelerating our path to profitability, notably in our largest market, Canada.”
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1737927/000156459020052540/cgc-10q_20200930.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Canopy Growth Corp.
Canopy Growth Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Rating
Learn More![]()
Upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event, Canopy Growth will have the right exercisable for a period of 30 days, to acquire all of the issued and outstanding Floating Shares for cash or common shares or a combination thereof, in Canopy Growth's sole discretion at a price equal to the 30-day volume weighted average trading price of the Floating Shares on the CSE, subject to a minimum call price of US$6.41 per Floating Share.
Additionally, we incurred operating costs of $26.8 million relating to facilities not yet cultivating or processing cannabis, not yet producing cannabis-related products or having under-utilized capacity, primarily related to start-up costs associated with our advanced manufacturing and beverage facilities in Smiths Falls, and our greenhouse in Denmark.
Immediately prior to the acquisition of the Fixed Shares, each issued and outstanding Fixed Multiple Share will automatically be exchanged for one Fixed Share and thereafter be acquired by Canopy Growth upon the same terms and conditions as the acquisition of the Fixed Shares; If the occurrence or waiver of the Triggering Event does not occur within 10 years from the date the Amended Arrangement was implemented (being September 23, 2020), Canopy Growth's rights to acquire both the Fixed Shares and the Floating Shares will terminate; Upon implementation of the Amended Arrangement, Canopy Growth made a cash payment to the shareholders of Acreage and holders of certain securities convertible into Existing SVS in the aggregate amount of US$37.5 million ($49.8 million); and Acreage is only permitted to issue an aggregate of up to 32,700,000 Fixed Shares and Floating Shares.
Further, we incurred operating costs of $10.5 million relating to facilities not yet cultivating or processing cannabis, not yet producing cannabis-related products or having under-utilized capacity, primarily related to start-up costs associated with our advanced manufacturing and beverage facilities in Smiths Falls and our greenhouse in Denmark.
Management calculates Adjusted EBITDA as the reported net (loss) income, adjusted to exclude income tax recovery (expense); other income (expense), net; loss on equity method investments; share-based compensation expense; depreciation and amortization expense; asset impairment and restructuring costs; expected credit losses on financial assets and related charges; and charges related to the flow-through of inventory step-up on business combinations, and further adjusted to remove acquisition-related costs.
Pursuant to the terms of...Read more
A decrease in interest income...Read more
A decrease in interest income...Read more
The decrease of $100.5 million...Read more
Following the occurrence or waiver...Read more
We undertake no obligation to...Read more
To date, we have incurred...Read more
We also benefited in the...Read more
We also benefited in the...Read more
In the second quarter of...Read more
The year-over-year decrease in the...Read more
CCAA Proceedings During the three...Read more
Additionally, This Works contributed a...Read more
The year-over-year decrease in the...Read more
However, increased competition in that...Read more
Our "Adjusted EBITDA" is a...Read more
The year-over-year increase is due...Read more
C (acquired in April 2019)...Read more
Additionally, This Works contributed revenue...Read more
The increase in the net...Read more
The increase in the net...Read more
The current quarter changes are...Read more
The year-over-year change from net...Read more
Additionally, we saw an increase...Read more
Accordingly, management believes that Adjusted...Read more
The current period changes are...Read more
Management believes that free cash...Read more
The year-over-year increase is primarily...Read more
The year-over-year decrease in the...Read more
In the six months ended...Read more
The following table presents Adjusted...Read more
The following table presents Adjusted...Read more
The year-over-year increase of $32.6...Read more
Revenue from Storz & Bickel...Read more
Partially offsetting these year-over-year fair...Read more
Partially offsetting these year-over-year fair...Read more
Therefore, we are subject to...Read more
The year-over-year increase is primarily...Read more
We took steps to reposition...Read more
The year-over-year decrease is primarily...Read more
The change from net income...Read more
The year-over-year increase of $19.4...Read more
As a result of the...Read more
Comparatively, in the six months...Read more
Given the uncertainties associated with...Read more
Partially offsetting these decreases in...Read more
A variety of factors, including...Read more
In September 2020, following receipt...Read more
These favorable year-over-year variances were...Read more
Partially offsetting these cost reductions...Read more
This Management's Discussion and Analysis...Read more
In connection with certain deferred...Read more
In connection with certain deferred...Read more
The year-over-year decrease in the...Read more
These forward-looking statements are generally...Read more
Change of $44.5 million related...Read more
In the six months ended...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Canopy Growth Corp provided additional information to their SEC Filing as exhibits
Ticker: CGC
CIK: 1737927
Form Type: 10-Q Quarterly Report
Accession Number: 0001564590-20-052540
Submitted to the SEC: Mon Nov 09 2020 4:31:32 PM EST
Accepted by the SEC: Mon Nov 09 2020
Period: Wednesday, September 30, 2020
Industry: Medicinal Chemicals And Botanical Products